研究業績

研究業績2022年度　英文原著

詳細
  1. Ando Y, Adams D, Benson MD, Berk JL, Planté-Bordeneuve V, Coelho T, Conceição I, Ericzon BG, Obici L, Rapezzi C, Sekijima Y, Ueda M, Palladini G, Merlini G: Guidelines and new directions in the therapy and monitoring of ATTRv amyloidosis Amyloid, 29, 143-155 , 2022

 

  1. Benson MD, Berk JL, Dispenzieri A, Damy T, Gillmore JD, Hazenberg BP, Lavatelli F, Picken MM, Röcken C, Schönland S, Ueda M, Westermark P: Tissue biopsy for the diagnosis of amyloidosis: experience from some centres. Amyloid, 29: 8-13, 2022

 

  1. Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM: Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging J Card Fail, 28, e1-e4 , 2022

 

  1. Hashimoto Y, Komori M, Tanji Y,　Ozeki A, Hirata K: Lasmiditan for single migraine attack in Japanese patients with cardiovascular risk factors: subgroup analysis of a phase 2 randomized placebo-controlled trial. Expert Opin Drug Saf 2022;21:1495-1503

 

  1. Hayashi H, Oda S, Kidoh M, Nakaura T, Morita K, Nagayama Y, Yoneda T, Takashio S, Misumi Y, Ueda M, Tsujita K, Hirai T: Can myocardial susceptibility quantification be an imaging biomarker for cardiac amyloidosis? Jpn J Radiol, 40: 500-507, 2022

 

  1. Ikura H, Kitakata H, Endo J, Moriyama H, Sano M, Tsujikawa H, Sawano M, Masuda T, Ohki T, Ueda M, Kosaki K, Fukuda K: Three patients of transthyretin amyloidosis in a Japanese family with amyloidogenic transthyretin Thr49Ser (p.Thr69Ser) variant. Eur J Med Genet, 65: 104451, 2022

 

  1. Inatomi Y, Nakajima M, Yonahara T: Cortical involvement of a recent infarct contralateral to early focal seizures in ischemic stroke. Intern Med , in press

 

  1. Inatomi Y, Suzuki Y, Yonehara T, Nakajima M: Tremor-like grasp phenomenon: case series study.Neurol Sci, 2022 Oct;43(10):5927-5932

 

  1. Inoue M, Higashi T, Hayashi Y, Onodera R, Fujisawa K, Taharabaru T, Yokoyama R, Ouchi K, Misumi Y, Ueda M, Inoue Y, Mizuguchi M, Saito T, Saido TC, Ando Y, Arima H, Motoyama K, Jono H: Multifunctional therapeutic cyclodextrin-appended dendrimer complex for treatment of systemic and localized amyloidosis ACS Appl Mater Interfaces, 14, 40599-40611, 2022

 

  1. Inoue M, Muta K, Fouad A, Mohammed A, Onodera R, Higashi T, Ueda M, ,Ando Y, Arima H, Jono H, Motoyama K: Potential use of Dendrimer-based TTR-CRISPR pDNA polyplex for ocular amyloidosis. Biol Pharm Bull, 45: 1660-1668, 2022

 

  1. Inoue M, Muta K, Mohammed AFA, Onodera R, Higashi T, Ouchi K, Ueda M, Ando Y, Arima H, Jono H, Motoyama K: Feasibility study of dendrimer-based TTR-CRISPR pDNA polyplex for ocular amyloidosis in vitro Biol Pharm Bull, 45, 1660-1668 , 2022

 

  1. Inoue Y, Nakajima M, Inatomi Y, Masuda T, Misumi Y, Nomura T, Uetani H, Hirai T, Ueda M: Reversible Periventricular Hyperintensity Lesions in Cerebral Amyloid Angiopathy: A Case Mimicking Cerebral Amyloid Angiopathy-related Inflammation. Intern Med. 2022 Dec 1;61(23):3581-3584

 

  1. Inoue Y, Tasaki M, Masuda T, Misumi Y, Nomura T, Ando Y, Ueda M: α-Enolase reduces cerebrovascular Aβ deposits by protecting Aβ amyloid formation Cell Mol Life Sci, 79, 462 , 2022

 

  1. Abe S, Tanaka T, Fukuma K, Matsubara S, Motoyama R, Mizobuchi M, Yoshimura H, Matsuki T, Manabe Y, Suzuki J, Ishiyama H, Tojima M, Kobayashi K, Shimotake A, Nishimura K, Koga M, Toyoda K, Murayama S, Matsumoto R, Takahashi R, Ikeda A, Ihara M: PROPOSE Study Investigators. Interictal epileptiform discharges as a predictive biomarker for recurrence of poststroke epilepsy. Brain Commun. 4: fcac312, 2022

 

  1. Iwahashi N, Ikezaki M, Komohara Y, Fujiwara Y, Noguchi T, Nishioka K, Sakai K, Nishio K, Ueda M, Ihara Y, Uchimura K, Ino K, Nishitsuji K: Cytoplasmic p53 aggregates accumulated in p53-mutated cancer correlate with poor prognosis. PNAS Nexus, 1: pgac128, 2022

 

  1. Kawano Y, Hata H, Takashio S, Tsujita K, Ueda M, Matsuoka M: Daratumumab, lenalidomide and dexamethasone in newly diagnosed systemic light chain amyloidosis patients associated with multiple myeloma. Br J Haematol, 198: e38-e41, 2022

 

  1. Kinoshita Y, Ikeda T, Miyamura T, Ueda Y, Yoshida Y, Ueda M, Haraoka S, Kushima H, Ishii H: Nodular Pulmonary Amyloidosis Associated with Sjögren’s Syndrome. Intern Med, 61: 877-881, 2022

 

  1. Maeda-Ogata S, Tahara N, Bekki M, Tahara A, Sugiyama Y, Honda A, Igata S, Abe T, Ueda M, Ando Y, Hirooka Y, Fukumoto Y: Carpal tunnel syndrome as an early red-flag sign of ATTRwt amyloidosis Nucl Cardiol, 29, 3562-3563 , 2022

 

  1. Matsushita H, Misumi Y, Masuda T, Okada M, Inoue F, Ueda M, Ando Y: Urinary transthyretin as a biomarker in ATTRv Val50Met amyloidosis Pathophysiology, 29, 333-343 , 2022

 

  1. Misumi Y, Ando Y, Ueda M: Early transverse tubule involvement in cardiomyocytes in hereditary transthyretin amyloidosis: a possible cause of cardiac events Cardiovasc Pathol, 61, 107458 , 2022

 

  1. Mizutani H, Sato Y, Yamazaki M, Yoshizawa T, Ando Y, Ueda M, Yamagata K: SIRT7 Deficiency　Protects against Aβ42-Induced Apoptosis through the Regulation of NOX4-Derived Reactive Oxygen　Species Production in SH-SY5Y Cells. Int J Mol Sci 23, 9027, 2022

 

  1. Morioka M, Takashio S, Nakashima N, Nishi M, Fujiyama A, Hirakawa K, Hanatani S, Usuku H, Yamamoto E, Kidoh M, Oda S, Matsushita K, Ueda M, Tsujita K: Correlation between cardiac images, biomarkers, and amyloid load in wild-type transthyretin amyloid cardiomyopathy. J Am Heart Assoc, 11:e024717, 2022

 

  1. Moriyama H, Kitakata H, Endo J, Ikura H, Sano M, Tasaki M, Sakai S, Ueda M, Fukuda K: Step-by-step typing for the accurate diagnosis of concurrent light chain and transthyretin cardiac amyloidosis. ESC Heart Fail, 9: 1474-1477, 2022

 

  1. Naganuma M, Inatomi Y, Yonehara T, Nakajima M, Ueda M: Underdosed Direct Oral Anticoagulants in Atrial Fibrillation Patients Reduce Stroke Severity and Improve Outcome. Cerebrovasc Dis. 2022;51(4):473-480

 

  1. Naiki H, Yamaguchi A, Sekijima Y, Ueda M, Ohashi K, Hatakeyama K, Ikeda Y, Hoshii Y, Shintani-Domoto Y, Miyagawa-Hayashino A, Tsujikawa H, Endo J, Arai T, Ando Y: Steep increase in the number of transthyretin-positive cardiac biopsy cases in Japan: evidence obtained by the nation-wide pathology consultation for the typing diagnosis of amyloidosis. Amyloid, 2023 (in press)

 

  1. Nakahara K, Nakajima M: Asymmetric skin temperature in Wallenberg syndrome. Neurol India 70:2326-2327, 2022

 

  1. Nakahara K, Takamatsu K, Kudo N, Ito T, Ueda M: Histopathological Features of Gerhardt Syndrome in a Patient With Multiple System Atrophy: An Autopsy Case Report. Cureus 14:e30415, 2022

 

  1. Nakajima M, Watari M, Ando Y, Ueda M: Asymptomatic deep venous thrombosis identified on routine screening in patients with hospitalized neurological diseases J Clin Neurosci, 102, 13-20 , 2022

 

  1. Nakashima N, Takashio S, Morioka M, Nishi M, Yamada T, Hirakawa K, Ishii M, Tabata N, Yamanaga K, Fujisue K, Sueta D, Kanazawa H, Hoshiyama T, Hanatani S, Araki S, Usuku H, Yamamoto E, Ueda M, Matsushita K, Tsujita K: A simple staging system using biomarkers for wild-type transthyretin amyloid cardiomyopathy in Japan. ESC Heart Fail, 9: 1731-1739, 2022

 

  1. Nishi M, Takashio S, Morioka M, Fujiyama A, Nakashima N, Hirakawa K, Hanatani S, Usuku H, Yamamoto E, Kidoh M, Oda S, Gushima R, Matsushita K, Fukushima S, Ueda M, Tsujita K: Extracardiac biopsy sensitivity in transthyretin amyloidosis cardiomyopathy patients with positive 99 mTc-labeled pyrophosphate scintigraphy findings. Circ J, 86:1113-1120, 2022

 

  1. Oike F, Usuku H, Yamamoto E, Marume K, Takashio S, Ishii M, Tabata N, Fujisue K, Yamanaga K, Sueta D, Hanatani S, Arima Y, Araki S, Oda S, Kawano H, Soejima H, Matsushita K, Ueda M, Fukui T, Tsujita K: Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis. ESC Heart Fail, 9: 1976-1986, 2022

 

  1. Quan D, Obici L, Berk JL, Ando Y, Aldinc E, White MT, Adams D: Impact of baseline polyneuropathy severity on patisiran treatment outcomes in the APOLLO trial Amyloid, 18, 1-10 , 2022

 

  1. Sato K, Oda S, Kidoh M, Ishiuchi S, Kamimoto M, Kanaya H, Nomura T, Kuyama N, Ueda M, Tsujita K, Hirai T: Myocarditis in myasthenia gravis: Multiparametric evaluation using cardiac magnetic resonance imaging. Circ J, 86:1788, 2022

 

  1. Shimamoto T, Uchino K, Mori A, Nojima K, Iijima J, Misumi Y, Ueda M, Uchino M: Effects of intensive exercise on cognitive dysfunction in patients with pure cerebellar degeneration: A single-arm pilot study. Ann Rehabil Med 46(5): 263-273, 2022

 

  1. Shinriki S, Hirayama M, Nagamachi A, Yokoyama A, Kawamura T, Kanai A, Kawai H, Iwakiri J, Riu L, Maeshiro M, Tungalag S, Tasaki M, Ueda M, Tomizawa K, Kataoka N, Ideue T, Suzuki Y, Asai K, Tani T, Inaba T, Matsui H: DDX41 coordinates RNA splicing and transcriptional elongation to prevent DNA replication stress in hematopoietic cells. Leukemia, 36: 2605-2620, 2022

 

  1. Singu T, Nakajima M, Ueda A, Nakahara K, Nomura T, Kojima S, Inoue T, Ueda M: Transient optic neuritis and perineuritis associated with anti-MOG antibody after SARS-CoV-2 mRNA vaccination. Neuroimmunol Rep 2: 100077, 2022

 

  1. Suda S, Abe A, Iguchi Y, Yagita Y, Kanzawa T, Okubo S, Ohara N, Mizunari T, Yamazaki M, Nakajima N, Kondo K, Fujimoto S, Inoue T, Iwanaga T, Terasawa Y, Shibazaki K, Kono Y, Nakajima M, Nakajima M, Mishina M, Adachi K, Imafuku I, Nomura K, Nagao T, Yaguchi H, Okamoto S, Osaki M, Kimura K: Characteristics of Ischemic Versus Hemorrhagic Stroke in Patients Receiving Oral Anticoagulants: Results of the PASTA Study.Intern Med. 2022 61 (6): 801-810

 

  1. Tahara N, Honda A, Ueda M, Fukumoto Y: Popeye’s sign and transthyretin amyloidosis. Eur Heart J, 43:3000, 2022

 

  1. Tahara N, Lairez O, Endo J, Okada A, Ueda M, Ishii T, Kitano Y, Lee H, Russo E, Kubo T: 99mTechnetium-pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathy. ESC Heart Fail, 9: 251-262, 2022

 

  1. Takahashi K, Morioka H, Sasaki D, Yamamura N, Kitazawa S, Ueda M, Sakaue T, Enomoto D, Uemura S, Okura T, Ikeda S: Two autopsy cases of wild-type transthyretin cardiac amyloidosis who died 10 days after technetium-99mpyrophosphate scintigraphy. J Nucl Cardiol, 2023 (in press)

 

  1. Takahashi K, Sasaki D, Yamashita M, Sakaue T, Enomoto D, Morioka H, Uemura S, Okura T, Ikeda S, Kono T, Hiratsuka Y, Saijo A, Yamamura N, Kitazawa S, Yamashita T, Ueda M: Amyloid deposit corresponds to technetium-99mpyrophosphate accumulation in abdominal fat of patients with transthyretin cardiac amyloidosis. J Nucl Cardiol, 29: 3126-3136, 2022

 

  1. Takahashi Y, Date H, Oi H, Adachi T, Imanishi N, Kimura E, Takizawa H, Kosugi S, Matsumoto N, Kosaki K, Matsubara Y: IRUD Consortium, Mizusawa H. Six years’ accomplishment of the Initiative on Rare and Undiagnosed Diseases: nationwide project in Japan to discover causes, mechanisms, and cures. J Hum Genet, 67: 505-513, 2022

 

  1. Takashio S, Morioka M, Ishii M, Morikawa K, Hirakawa K, Hanatani S, Oike F, Usuku H, Kidoh M, Oda S, Yamamoto E, Matsushita K, Ueda M, Tsujita K: Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild-type transthyretin amyloid cardiomyopathy. ESC Heart Fail, 2023 (in press)

 

  1. Takashio S, Tokitsu T, Matsukawa M, Sakaino N, Fujimoto K, Sakamoto T, Noda K, Tsunoda R, Misumi I, Hirai N, Doi H, Koide S, Mizuno Y, Hirose T, Kurokawa H, Kajiwara I, Ohba K, Miyamoto S, Araki S, Yamamoto E, Matsushita K, Ueda M, Tsujita K: Kumamoto Cardiac Amyloid Survey Investigators. Incidence, clinical characteristics, and diagnostic approach in transthyretin amyloid cardiomyopathy: The Kumamoto Cardiac Amyloidosis Survey. J Cardiol, 80: 49-55, 2022

 

  1. Takashio S, Yamada T, Nishi M, Morioka M, Nakashima N, Hirakawa K, Hanatani S, Usuku H, Yamamoto E, Ueda M, Matsushita K, Kaikita K, Tsujita K: Sex-related differences in the clinical characteristics of wild-type transthyretin amyloidosis cardiomyopathy. J Cardiol, 79: 50-57, 2022

 

  1. Takeuchi Y, Nomura T, Nakahara K, Ueda M.: Autoimmune polyglandular syndrome with refractory gait disturbance. Intern Med, 2023 (in press)

 

  1. Tanaka H, Nishida-Fukuda H, Wada M, Tokuhiro K, Matsushita H, Ando Y: Inhibitory effect of the HASPIN inhibitor CHR-6494 on BxPC-3-Luc, A luciferase-expressing pancreatic cancer cell line Cell J, 24, 212-214 , 2022

 

  1. Taniguchi A, Shindo A, Tabei KI, Onodera O, Ando Y, Urabe T, Kimura K, Kitagawa K, Miyamoto Y, Takegami M, Ihara M, Mizuta I, Mizuno T, Tomimoto H: Imaging characteristics for predicting cognitive impairment in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy Front Aging Neurosci, 14, 876437 , 2022

 

  1. Tasaki M, Misumi Y, Nomura T, Kamba T, Ueda M: Detection of semenogelin 1 amyloidosis through immunohistochemical staining with novel antiserum developed based on mass spectrometric peptide mapping analysis. Amyloid 29: 278-280, 2022

 

  1. Tasaki M, Nomura T, Uchiyama K, Misumi Y, Nakahara K, Oyama Y, Uesugi N, Ueda M: Fibrinogen Aalpha-chain amyloidosis associated with a rare frameshift pathogenic variant p. Arg547GlyfsTer21. Amyloid, 29: 276-277, 2022

 

  1. Tasaki M, Oishi T, Ueda M: EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1) amyloid deposits in the lower rectum from aged patient with bloody stools. Pathol Int, 72: 217-218, 2022

 

  1. Ueda A, Nakajima M, Misumi Y, Nakahara K, Shinriki S, Tasaki M, Matsui H, Ueda M: Detection of Vascular Notch3 Deposits in Unfixed Frozen Skin Biopsy Sample in CADASIL. Front Neurol 13: 881528, 2022

 

  1. Ueda M: Transthyretin: its function and amyloid formation. Neurochem Int. 155: 105313, 2022

 

  1. Usuku H, Takashio S, Yamamoto E, Yamada T, Egashira K, Morioka M, Nishi M, Komorita T, Oike F, Tabata N, Ishii M, Yamanaga K, Fujisue K, Sueta D, Arima Y, Araki S, Oda S, Misumi Y, Kawano H, Matsushita K, Ueda M, Matsui H, Tsujita K: Prognostic value of right ventricular global longitudinal strain in transthyretin amyloid cardiomyopathy. J Cardiol 80: 56-63, 2022

 

  1. Usuku H, Yamamo E, Sueta D, Noguchi M, Fujisaki T, Egashira K, Morioka M, Komorita T, Oike F, Fujisue K, Hanatani S, Arima Y, Takashio S, Oda S, Kawano H, Matsushita K, Ueda M, Matsui H, Tsujita K: Time-dependent change of relative apical longitudinal strain index in patients with wild-type transthyretin amyloid cardiomyopathy. Int J Cardiol Heart Vasc, 43, 101146, 2022

 

  1. Yagita K, Noguchi H, Koyama S, Hamasaki H, Komori T, Aishima S, Kosaka T, Ueda M, Komohara Y, Watanabe A, Sasagasako N, Ninomiya T, Oda Y, Honda H: Chronological changes in the expression pattern of hippocampal prion proteins during disease progression in sporadic Creutzfeldt-Jakob disease MM1 subtype. J Neuropathol Exp Neurol. 2022 Oct 18; 81: 900-909

 

  1. Yamakawa M, Nakahara K, Nakanishi T, Nomura T, Ueda M: Miller Fisher syndrome following vaccination against SARS-CoV-2: a case report. Intern Med 61:1067-1069, 2022

 

  1. Yamakawa M, Nakane S, Ihara E, Tawara N, Ikeda H, Igarashi Y, Komohara Y, Takamatsu K, Ikeda T, Tomita Y, Murai S, Ando Y, Mukaino A, Ogawa Y, Ueda M: A novel murine model of autoimmune dysautonomia by α3 nicotinic acetylcholine receptor immunization Front Neurosci, 16, 1006923 , 2022

 

  1. Yamasaki Y, Mukaino A, Yamashita S, Takeuchi Y, Tawara N, Yoshida R, Honda Y, Yamashita T, Kakimoto A, Ueyama H, Ando Y: Macroglossia in rapidly progressive inclusion body myositis Neuropathology, Online ahead of print , 2022

 

  1. Yi K, Nakajima M, Ikeda T, Yoshigai M, Ueda M: Modified Rankin scale assessment by telephone using a simple questionnaire. Journal of Stroke and Cerebrovascular Diseases, 31(10), 2022

 

  1. Yoshimoto T, Yamagami H, Sakai N, Toyoda K, Hashimoto Y, Hirano T, Iwama T, Goto R, Kimura K, Kuroda S, Matsumaru Y, Miyamoto S, Ogasawara K, Okada Y, Shiokawa Y, Takagi Y, Tominaga T, Uno M, Yoshimura S, Ohara N, Imamura H, Sakai C: I mpact of COVID-19 on the Volume of Acute Stroke Admissions: a Nationwide Survey in Japan. Neurol Med Chir(Tokyo) 62: 369-376, 2022 Doi: 10.2176/jns-nmc.2022-0099

 

  1. Yoshimura H, Tanaka T, Fukuma K, Matsubara S, Motoyama R, Mizobuchi M, Matsuki T, Manabe Y, Suzuki J, Kobayashi K, Shimotake A, Nishimura K, Onozuka D, Kawamoto M, Koga M, Toyoda K, Murayama S, Matsumoto R, Takahashi R, Ikeda A, Ihara M: Prognostic value of right ventricular global an imaging b and Mortality in Patients With Poststroke Epilepsy. 99: e376-e384, 2022

 

  1. Yumoto S, Doi K, Higashi T, Shimao Y, Ueda M, Ishihara A, Adachi Y, Ishiodori H, Honda S, Baba H: Intra-abdominal bleeding caused by amyloid transthyretin amyloidosis in the gastrointestinal tract: a case report. Clin J Gastroenterol, 15: 140-145, 2022

 

  1. Sumia K, Masuda T, Kimura N, Akiyoshi Y, Obayashi K, Matsubara E. Cerebrospinal fluid B-cell activating factor levels as a novel biomarker in patients with neurosarcoidosis. J Neurol Sci, 2023 (in press)
Copyright© Department of Neurology, Graduate School of Medical Sciences, Kumamoto University.